BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21139082)

  • 1. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.
    Billot K; Soeur J; Chereau F; Arrouss I; Merle-Béral H; Huang ME; Mazier D; Baud V; Rebollo A
    Blood; 2011 Feb; 117(6):1917-27. PubMed ID: 21139082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia.
    Duhamel M; Arrouss I; Merle-Béral H; Rebollo A
    Blood; 2008 Mar; 111(6):3225-8. PubMed ID: 18184862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
    Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
    J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.
    Kuehn HS; Chang J; Yamashita M; Niemela JE; Zou C; Okuyama K; Harada J; Stoddard JL; Nunes-Santos CJ; Boast B; Baxter RM; Hsieh EWY; Garofalo M; Fleisher TA; Morio T; Taniuchi I; Dutmer CM; Rosenzweig SD
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34694366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
    Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
    Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
    Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
    Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.
    Marteau JB; Rigaud O; Brugat T; Gault N; Vallat L; Kruhoffer M; Orntoft TF; Nguyen-Khac F; Chevillard S; Merle-Beral H; Delic J
    BMC Med Genomics; 2010 Nov; 3():53. PubMed ID: 21062507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential epigenetic regulation of Aiolos expression in human tumoral cell lines and primary cells.
    Duhamel M; Navarro P; Cario-Andre M; Billot K; Arrouss I; Rebollo A
    FEBS Lett; 2008 Feb; 582(3):457-67. PubMed ID: 18206652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical function of Ikaros in controlling Aiolos gene expression.
    Ghadiri A; Duhamel M; Fleischer A; Reimann A; Dessauge F; Rebollo A
    FEBS Lett; 2007 Apr; 581(8):1605-16. PubMed ID: 17383641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIOLOS Variants Causing Immunodeficiency in Human and Mice.
    Yamashita M; Morio T
    Front Immunol; 2022; 13():866582. PubMed ID: 35444653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
    Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
    Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
    Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
    Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
    Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
    Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of AIOLOS inhibits cell proliferation and suppresses apoptosis in Nalm-6 cells.
    Zhuang Y; Li D; Fu J; Shi Q; Lu Y; Ju X
    Oncol Rep; 2014 Mar; 31(3):1183-90. PubMed ID: 24399134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells.
    Ougolkov AV; Bone ND; Fernandez-Zapico ME; Kay NE; Billadeau DD
    Blood; 2007 Jul; 110(2):735-42. PubMed ID: 17463171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
    Capitani N; Lucherini OM; Sozzi E; Ferro M; Giommoni N; Finetti F; De Falco G; Cencini E; Raspadori D; Pelicci PG; Lauria F; Forconi F; Baldari CT
    Blood; 2010 May; 115(18):3726-36. PubMed ID: 20061561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.